Effect of hypoxemia and cardiovascular co-morbidity on quality of life and certain clinical and functional parameters of patients with chronic obstructive pulmonary disease
https://doi.org/10.18093/0869-0189-2011-0-4-54-57
Abstract
Summary. Clinical and functional status including quality of life, CAT test and BODE index in relation to level of hypoxemia was assessed in 44 patients with COPD only and in 35 patients with COPD and cardiovascular co-morbidity (ischemic disease heart and systemic hypertension). CAT score, BODE index and MRS score were higher and 6-min walking distance was shorter in hypoxemic COPD patients n comparison to COPD patients without hypoxemia. The most significant disorders were seen in COPD patients with cardiovascular co-morbidity. CAT is a simple and effective test to assess the impact of disease on health status in COPD patients with cardiovascular co-morbidity and hypoxemia.
About the Author
M. F. Kinyaykin
ГОУ ВПО "Владивостокский государственный медицинский университет" Минздравсоцразвития РФ
Russian Federation
Russian Federation
References
1. Сенкевич Н.Ю., Ханова Ф.М., Сафрыгин К.В. Четыре вопроса о качестве жизни. Атмосфера. Пульмонол. и аллергол. 2002; 4: 26–28.
2. Черняк Б.А., Трофименко И.Н. Качество жизни у больных хронической обструктивной болезнью легких. В кн.: Чучалин А.Г. (ред.). Хроническая обструктивная болезнь легких. М.: Атмосфера; 2008. 332–339.
3. Cazzola M., MacNee W., Martinez F.J. et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur. Respir. J. 2008; 31: 416–469.
4. Jones P.W., Harding G., Berry P. et al. Development and first validation of the COPD Assessment Test. Eur. Respir. J. 2009; 34: 648–654.
5. Чучалин А.Г., Белевский А.С., Черняк Б.А. и др. Качество жизни больных хронической обструктивной болезнью легких в России: результаты многоцентрового популяционного исследования "ИКАР-ХОБЛ". Пульмонология 2005; 1: 93–102.
6. Jones P.W. St. George,s respiratory questionnaire: development, interpretation and use. Eur. Respir. Rev. 2002; 12: 63–64.
7. Celli B.R., Cote C.G., Marin J.M. et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 1005–1012.
8. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. The association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax 2004; 59: 574–580.
9. Авдеев С.Н. Хроническая обструктивная болезнь легких как системное заболевание. В кн.: Чучалин А.Г. (ред.). Хроническая обструктивная болезнь легких. М.: Атмосфера; 2008: 131–149.
10. Киняйкин М.Ф., Суханова Г.И., Удовиченко И.А., Кондрашова Е.А. Миокардиальные повреждения у больных хронической обструктивной болезнью легких. Пульмонология 2008; 5: 71–74.
11. Киняйкин М.Ф., Суханова Г.И., Беседнова Н.Н. и др. Роль гипоксемии и системного воспаления в формировании легочной гипертензии и хронического легочного сердца у больных хронической обструктивной болезнью легких. Дальневосточ. мед. журн. 2010; 1: 6–8.
12. Enright P.L., Sherrill D.L. Reference equations for the sixminute walk in healthy adults. Am. J. Respir. Crit. Care Med. 1998; 158: 1384–1391.
13. Bestall J.C., Paul E.A., Garrod R. et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54 (7): 581–586.
14. Bestall J.C., Paul E.A., Garrod R. et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54 (7): 581–586.
Review
For citations:
Kinyaykin M.F. Effect of hypoxemia and cardiovascular co-morbidity on quality of life and certain clinical and functional parameters of patients with chronic obstructive pulmonary disease. PULMONOLOGIYA. 2011;(4):54-57. (In Russ.) https://doi.org/10.18093/0869-0189-2011-0-4-54-57
Views:
613
Email this article 